nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.101	0.138	CbGpPWpGaD
Fexofenadine—Fluspirilene—ADRA2A—attention deficit hyperactivity disorder	0.0358	0.203	CrCbGaD
Fexofenadine—Pimozide—DRD3—attention deficit hyperactivity disorder	0.0294	0.166	CrCbGaD
Fexofenadine—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0274	0.0375	CbGpPWpGaD
Fexofenadine—Fluspirilene—SLC6A4—attention deficit hyperactivity disorder	0.0273	0.155	CrCbGaD
Fexofenadine—Fluspirilene—DRD2—attention deficit hyperactivity disorder	0.0272	0.154	CrCbGaD
Fexofenadine—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0269	0.0367	CbGpPWpGaD
Fexofenadine—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0231	0.0315	CbGpPWpGaD
Fexofenadine—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0226	0.0309	CbGpPWpGaD
Fexofenadine—Fluspirilene—HTR2A—attention deficit hyperactivity disorder	0.021	0.119	CrCbGaD
Fexofenadine—Pimozide—DRD2—attention deficit hyperactivity disorder	0.0203	0.115	CrCbGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0179	0.0244	CbGpPWpGaD
Fexofenadine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0163	0.0223	CbGpPWpGaD
Fexofenadine—Pimozide—HTR2A—attention deficit hyperactivity disorder	0.0157	0.0888	CrCbGaD
Fexofenadine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0157	0.0214	CbGpPWpGaD
Fexofenadine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0151	0.0207	CbGpPWpGaD
Fexofenadine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0147	0.02	CbGpPWpGaD
Fexofenadine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0144	0.0197	CbGpPWpGaD
Fexofenadine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0142	0.0195	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0139	0.0191	CbGpPWpGaD
Fexofenadine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0137	0.0187	CbGpPWpGaD
Fexofenadine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0133	0.0181	CbGpPWpGaD
Fexofenadine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0127	0.0174	CbGpPWpGaD
Fexofenadine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0123	0.0168	CbGpPWpGaD
Fexofenadine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0121	0.0166	CbGpPWpGaD
Fexofenadine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.012	0.0164	CbGpPWpGaD
Fexofenadine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0111	0.0152	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.011	0.015	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00937	0.0128	CbGpPWpGaD
Fexofenadine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00929	0.0127	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00907	0.0124	CbGpPWpGaD
Fexofenadine—SLCO2B1—forebrain—attention deficit hyperactivity disorder	0.00877	0.096	CbGeAlD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00866	0.0118	CbGpPWpGaD
Fexofenadine—SLCO1A2—forebrain—attention deficit hyperactivity disorder	0.00807	0.0883	CbGeAlD
Fexofenadine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00781	0.0107	CbGpPWpGaD
Fexofenadine—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00751	0.0103	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00709	0.00968	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00676	0.00924	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00621	0.00849	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00557	0.00761	CbGpPWpGaD
Fexofenadine—SLCO1A2—midbrain—attention deficit hyperactivity disorder	0.00533	0.0583	CbGeAlD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00531	0.00726	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0053	0.00724	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00519	0.00709	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00515	0.00704	CbGpPWpGaD
Fexofenadine—HRH1—forebrain—attention deficit hyperactivity disorder	0.00494	0.0541	CbGeAlD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00485	0.00663	CbGpPWpGaD
Fexofenadine—SLCO2B1—nervous system—attention deficit hyperactivity disorder	0.00476	0.0521	CbGeAlD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00476	0.0065	CbGpPWpGaD
Fexofenadine—SLCO2B1—central nervous system—attention deficit hyperactivity disorder	0.00459	0.0502	CbGeAlD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00454	0.00621	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00454	0.0062	CbGpPWpGaD
Fexofenadine—SLCO2B1—cerebellum—attention deficit hyperactivity disorder	0.00448	0.049	CbGeAlD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00445	0.00607	CbGpPWpGaD
Fexofenadine—SLCO1A2—nervous system—attention deficit hyperactivity disorder	0.00438	0.048	CbGeAlD
Fexofenadine—SLCO1A2—central nervous system—attention deficit hyperactivity disorder	0.00422	0.0462	CbGeAlD
Fexofenadine—SLCO1A2—cerebellum—attention deficit hyperactivity disorder	0.00412	0.0451	CbGeAlD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00381	0.00521	CbGpPWpGaD
Fexofenadine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00376	0.0411	CbGeAlD
Fexofenadine—SLCO2B1—brain—attention deficit hyperactivity disorder	0.00364	0.0398	CbGeAlD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0036	0.00491	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00346	0.00472	CbGpPWpGaD
Fexofenadine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0034	0.00465	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00338	0.00463	CbGpPWpGaD
Fexofenadine—SLCO1A2—brain—attention deficit hyperactivity disorder	0.00335	0.0367	CbGeAlD
Fexofenadine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00332	0.00453	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00326	0.00445	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00316	0.00431	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00314	0.0043	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00308	0.00421	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00292	0.00399	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00291	0.00398	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00283	0.00387	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00278	0.0038	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00275	0.00375	CbGpPWpGaD
Fexofenadine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.0027	0.0296	CbGeAlD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00269	0.00368	CbGpPWpGaD
Fexofenadine—HRH1—nervous system—attention deficit hyperactivity disorder	0.00268	0.0294	CbGeAlD
Fexofenadine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00264	0.00361	CbGpPWpGaD
Fexofenadine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.00258	0.0283	CbGeAlD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00256	0.0035	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0025	0.00342	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00247	0.00337	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00242	0.00331	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00238	0.00326	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00238	0.00326	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00235	0.00322	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00235	0.00321	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00235	0.00321	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00232	0.00317	CbGpPWpGaD
Fexofenadine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00229	0.025	CbGeAlD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00227	0.00311	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00219	0.003	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00207	0.00283	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00205	0.0028	CbGpPWpGaD
Fexofenadine—HRH1—brain—attention deficit hyperactivity disorder	0.00205	0.0224	CbGeAlD
Fexofenadine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00204	0.0223	CbGeAlD
Fexofenadine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00197	0.0215	CbGeAlD
Fexofenadine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00195	0.00267	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00194	0.00265	CbGpPWpGaD
Fexofenadine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00192	0.021	CbGeAlD
Fexofenadine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00191	0.00261	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00191	0.00261	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00185	0.00252	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00184	0.00252	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00182	0.00249	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00182	0.00248	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00181	0.00247	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00179	0.00245	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00179	0.00245	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00179	0.00245	CbGpPWpGaD
Fexofenadine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00179	0.0195	CbGeAlD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00178	0.00243	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00177	0.00242	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00174	0.00237	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.0017	0.00232	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00167	0.00228	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00166	0.00226	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00162	0.00221	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00162	0.00221	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00159	0.00218	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00158	0.00216	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00156	0.00213	CbGpPWpGaD
Fexofenadine—CYP2D6—brain—attention deficit hyperactivity disorder	0.00156	0.0171	CbGeAlD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00154	0.0021	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00148	0.00203	CbGpPWpGaD
Fexofenadine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00147	0.0161	CbGeAlD
Fexofenadine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00141	0.0155	CbGeAlD
Fexofenadine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00138	0.0151	CbGeAlD
Fexofenadine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00133	0.00181	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.0013	0.00177	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00127	0.00174	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00127	0.00174	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00125	0.00171	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00123	0.00169	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00122	0.00167	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.0012	0.00165	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00117	0.0016	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00116	0.00159	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00116	0.00158	CbGpPWpGaD
Fexofenadine—ABCB1—brain—attention deficit hyperactivity disorder	0.00112	0.0123	CbGeAlD
Fexofenadine—SLCO1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00109	0.00149	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00109	0.00149	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00108	0.00147	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00107	0.00146	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00105	0.00144	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00105	0.00143	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00104	0.00143	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00103	0.0014	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00103	0.0014	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00102	0.00139	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00101	0.00138	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00101	0.00138	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000996	0.00136	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000982	0.00134	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000978	0.00134	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000975	0.00133	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000969	0.00132	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000948	0.00129	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000946	0.00129	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000944	0.00129	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000931	0.00127	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00092	0.00126	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000871	0.00119	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000857	0.00117	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000829	0.00113	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000829	0.00113	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00079	0.00108	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000772	0.00105	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000766	0.00105	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000762	0.00104	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000744	0.00102	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000743	0.00102	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000711	0.000972	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000661	0.000903	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.00066	0.000901	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000655	0.000895	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000635	0.000868	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000622	0.00085	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.0006	0.00082	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000578	0.00079	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00056	0.000765	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00055	0.000752	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000545	0.000745	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000545	0.000745	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000543	0.000743	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000536	0.000733	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000514	0.000702	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000514	0.000702	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000506	0.000692	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000505	0.000691	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000499	0.000681	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00047	0.000642	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000436	0.000595	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000421	0.000575	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000415	0.000567	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000411	0.000561	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000391	0.000534	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000355	0.000484	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000331	0.000452	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.00033	0.000451	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000328	0.000448	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000311	0.000425	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000309	0.000422	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000283	0.000387	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000188	0.000257	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000142	0.000194	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000133	0.000182	CbGpPWpGaD
